Thank you for standing by, and welcome to the Krystal Biotech 4Q 2025 Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded. I would now like to hand the ...

Krystal Biotech, Inc. (NASDAQ:KRYS) Q4 2025 Earnings Call Transcript February 17, 2026 Krystal Biotech, Inc. beats earnings ...

Extracellular vesicles (EVs) are tiny biological bubbles that carry nucleic acids and proteins between cells, playing an essential role in tissue repair, neuroprotection and immune health. By ...

To test the accuracy of the Octet ® assay, Fc-fusion protein was spiked into CCM and HCP matrices at known concentrations in ...

Herpes simplex virus type 1 (HSV-1) infection dramatically remodels the host cell's nuclear structures. Infection leads to ...

Researchers in China recently published a study in Science Translational Medicine describing a new antibody cocktail for ...

Krystal Biotech (NASDAQ:KRYS) reported fourth-quarter 2025 net revenue from VYJUVEK of $107.1 million, extending what management described as continued launch momentum in the U.S. and early traction ...

Innovations in imaging and genetic engineering are coming together to probe the biophysics of cytoplasm inside living animals.

French small modular reactor developer Blue Capsule Technology has announced the start of construction of ELISE - a full-size test rig for sodium at high temperatures - at Peyrolles-en-Provence, in ...

Picture this: an excavator scoots dirt around without a puff of black smoke—just a tiny wisp of water vapor trailing behind. That’s exactly what Obayashi Co ...

The authors develop an in vitro human epiblast model and show that early TGFβ family inhibition prevents epithelial identity but is dispensable for its maintenance after epithelium formation.